Risk reduced for primary cardiovascular event, but no reduction seen in risk for death from any cause, dementia, or persistent physical disability ...

For women with autoimmune disease who had received autologous CD19-chimeric antigen receptor (CAR) T-cell therapy, pregnancies seem to be uncomplicated without disease reactivation, according to a ...

Proportion of women never screened for cervical cancer increased, with more pronounced increase from 2010 to 2023 ...

FDA adds a boxed warning to ferric carboxymaltose prescribing information, emphasizing severe low phosphate risks and mandatory monitoring protocols.

Significant improvement seen in self-reported brain fog, concentration, working memory, processing speed, verbal memory, problem solving.

The phase 3 REMODEL-1/-2 trials demonstrated the superiority of remibrutinib vs teriflunomide in reducing annualized relapse rate in RMS patients.

HealthDay News — Lower adherence to blood pressure-lowering medication is associated with no benefit for preventing cardiovascular events, according to a study presented at the annual meeting of the ...

HealthDay News — Unintentional ingestion of recreational drugs increased substantially in US children younger than 6 years of age from 2000 to 2024, according to a study published online June 24 in ...

FDA approves updated 2026-2027 COVID-19 vaccine formulations targeting the XFG variant for older adults and high-risk ...

Lisraya is the first oral dual TYK2/JAK1 inhibitor indicated for adults with dermatomyositis, demonstrating significant ...

Effective atrial fibrillation management requires rate or rhythm control, anticoagulation based on risk scores, and lifestyle ...